Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine in premanifest Huntington's disease
NCT00592995Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2007
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of creatine in Huntington disease (HD), sponsored by Massachusetts General Hospital. Started Dec 2007; status: completed.
02
Drugs
creatine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NCT00592995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592995.